Xingwang Xie

1.4k total citations
42 papers, 1.1k citations indexed

About

Xingwang Xie is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xingwang Xie has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Oncology and 14 papers in Immunology. Recurrent topics in Xingwang Xie's work include Hepatitis B Virus Studies (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immune Cell Function and Interaction (7 papers). Xingwang Xie is often cited by papers focused on Hepatitis B Virus Studies (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immune Cell Function and Interaction (7 papers). Xingwang Xie collaborates with scholars based in China. Xingwang Xie's co-authors include Hongsong Chen, Lai Wei, Ran Fei, Henghui Zhang, Xueyan Wang, Gaixia He, Jinxue Zhou, Yanhui Chen, Hui Zeng and Yaxian Kong and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Xingwang Xie

40 papers receiving 1.1k citations

Peers

Countries citing papers authored by Xingwang Xie

Since Specialization

Citations

This map shows the geographic impact of Xingwang Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingwang Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingwang Xie more than expected).

Fields of papers citing papers by Xingwang Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingwang Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingwang Xie. The network helps show where Xingwang Xie may publish in the future.

Co-authorship network of co-authors of Xingwang Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Xingwang Xie. A scholar is included among the top collaborators of Xingwang Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingwang Xie. Xingwang Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Novel nanoparticle-combined therapy through EGFR and PD-L1 blockade: PFPR-siRNA-mediated suppressing NSCLC proliferation via PDT and enhanced antitumor immunity	Colloids and Surfaces B Biointerfaces	Meiling Zhang, Ning Xie et al.	0
2	Down-regulation of zinc finger protein 335 undermines natural killer cell function in mouse colitis-associated colorectal carcinoma	Heliyon	Bin Jiang, Hongjian Zhou et al.	1
3	GTP binding protein 2 maintains the quiescence, self-renewal, and chemoresistance of mouse colorectal cancer stem cells via promoting Wnt signaling activation	Heliyon	Hongjian Zhou, Xingwang Xie et al.	1
4	Toward a comprehensive solution for treating solid tumors using T-cell receptor therapy: A review	European Journal of Cancer	Peiwen Ma, Yale Jiang et al.	6
5	Primary duodenal papilla lymphoma producing obstructive jaundice: a case report	BMC Surgery	Sheng Tai, Xingwang Xie et al.	3
6	Zinc finger protein 852 is essential for the proliferation, drug sensitivity, and self‐renewal of gastric cancer cells	Cell Biology International	Hongjian Zhou, Bin Jiang et al.	3
7	NKp46+ lamina propria natural killer cells undergo metabolic reprogramming in a mouse experimental colitis model	Inflammation Research	Hongjian Zhou, Xingwang Xie et al.	2
8	Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma.	PubMed Central	Wensi Zhao, Wanpu Yan et al.	24
9	Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis	Chinese Medical Journal	Dongbo Chen, Yangjing Zhao et al.	19
10	Genomic alterations across six hepatocellular carcinoma cell lines by panel-based sequencing	Translational Cancer Research	Yangjing Zhao, Yanhui Chen et al.	5
11	PPPDE1 is a novel deubiquitinase belonging to a cysteine isopeptidase family	Biochemical and Biophysical Research Communications	Xingwang Xie, Xueyan Wang et al.	18
12	The transcription factor RFX5 is a transcriptional activator of the TPP1 gene in hepatocellular carcinoma	Oncology Reports	Yangjing Zhao, Xingwang Xie et al.	25
13	Antibodies Targeting Novel Neutralizing Epitopes of Hepatitis C Virus Glycoprotein Preclude Genotype 2 Virus Infection	PLoS ONE	Ruyu Liu, Huiying Rao et al.	8
14	Direct-acting Antiviral Agents Resistance-associated Polymorphisms in Chinese Treatment-naïve Patients Infected with Genotype 1b Hepatitis C Virus	Chinese Medical Journal	Ye Wang, Huiying Rao et al.	10
15	Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma	Journal of Experimental & Clinical Cancer Research	Gaixia He, Henghui Zhang et al.	217
16	Deep sequencing of hepatitis B virus basal core promoter and precore mutants in HBeAg-positive chronic hepatitis B patients	Scientific Reports	Linlin Yan, Henghui Zhang et al.	16
17	2’,3’-Cyclic Nucleotide 3’-Phosphodiesterases Inhibit Hepatitis B Virus Replication	PLoS ONE	Hui Ma, Xingliang Zhao et al.	7
18	Determination of the Human Antibody Response to the Neutralization Epitopes Encompassing Amino Acids 313–327 and 432–443 of Hepatitis C Virus E1E2 Glycoproteins	PLoS ONE	Ruyu Liu, Huiying Rao et al.	6
19	FOXP3 gene polymorphism is associated with hepatitis B-related hepatocellular carcinoma in China	Journal of Experimental & Clinical Cancer Research	Yanhui Chen, Weijia Liao et al.	34
20	[Correlation between interleukin-28B genetic polymorphisms and primary hepatocellular carcinoma].	PubMed	Yan Wang, Henghui Zhang et al.	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact